A drug that can prolong the lives of people with advanced skin cancer has been approved for widespread use on the NHS. It has now been approved by the National Institute for Health and Care Excellence for treating advanced skin cancer in patients who have already tried another drug, ipilimumab.
Are you up for a challenge?
